Masahide Mori

2.4k total citations
110 papers, 1.4k citations indexed

About

Masahide Mori is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Masahide Mori has authored 110 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 17 papers in Surgery. Recurrent topics in Masahide Mori's work include Lung Cancer Treatments and Mutations (38 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Masahide Mori is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Masahide Mori collaborates with scholars based in Japan, United States and Australia. Masahide Mori's co-authors include Hiroshi Kida, Isao Tachibana, Soichiro Yokota, Seiji Hayashi, Hiroto Matsuoka, Sho Goya, Yukihiro Yano, Tadashi Osaki, Toshihiko Yamaguchi and Toru Arai and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Masahide Mori

104 papers receiving 1.3k citations

Peers

Countries citing papers authored by Masahide Mori

Since Specialization

Citations

This map shows the geographic impact of Masahide Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahide Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahide Mori more than expected).

Fields of papers citing papers by Masahide Mori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahide Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahide Mori. The network helps show where Masahide Mori may publish in the future.

Co-authorship network of co-authors of Masahide Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Masahide Mori. A scholar is included among the top collaborators of Masahide Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahide Mori. Masahide Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real‐World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in Japan 2025 ·Thoracic Cancer ·Shimpei Miyamoto, (unknown), Hanako Kuhara, (unknown), Takayuki Shiroyama, Motohiro Tamiya, Akihiro Tamiya, Kazumi Nishino, Yoshito Takeda, Takashi Kijima, Meinoshin Okumura, Atsushi Kumanogoh, Masahide Mori	1
2	Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study 2025 ·European Journal of Cancer ·(unknown), Kinnosuke Matsumoto, Akihiro Tamiya, Motohiro Tamiya, Masahide Mori, Hidekazu Suzuki, Takayuki Shiroyama, (unknown), (unknown), (unknown), (unknown), (unknown), Tomoki Kuge, Yuhei Kinehara, Koji Azuma, (unknown), (unknown), Yoshito Takeda, Atsushi Kumanogoh	0
3	Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer 2024 ·Lung Cancer ·Akihiro Tamiya, (unknown), Daijiro Harada, Shun‐ichi Isa, Yoshihiko Taniguchi, (unknown), (unknown), Tsutomu Shinohara, (unknown), Katsumi Nakatomi, Masahide Oki, Masahide Mori, (unknown), Koji Yamazaki, Atsuhisa Tamura, Masahiko Ando, Yasuhiro Koh	4
4	Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study 2024 ·Targeted Oncology ·Kinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, Tomoki Kuge, Masahide Mori, Motohiro Tamiya, Yuhei Kinehara, Akihiro Tamiya, Hidekazu Suzuki, (unknown), Kiyonobu Ueno, (unknown), Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh	0
5	Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan 2023 ·Thoracic Cancer ·Mototsugu Shimokawa, Masaki Kanazu, Ryusei Saito, Masahide Mori, Atsuhisa Tamura, Yoshio Okano, Yuka Fujita, Takeo Endo, Mitsuru Motegi, Shohei Takata, Toshiyuki Kita, Noriaki Sukoh, (unknown), Mitsuhiro Takenoyama, Shinji Atagi	1
6	Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312) 2023 ·Lung Cancer ·Nobuyuki Katakami, Takashi Nishimura, (unknown), Akito Hata, Kazumi Nishino, Masahide Mori, Tomonori Hirashima, (unknown), Toshihiko Kaneda, Hisashi Ohnishi, Satoshi Morita, Yukimasa Hatachi	2
7	A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19 2023 ·Scientific Reports ·Kota Iwahori, Takuro Nii, (unknown), Takahiro Kawasaki, (unknown), Kazuki Hashimoto, Takanori Matsuki, Kazuyuki Tsujino, Keisuke Miki, Akio Osa, Sho Goya, (unknown), Masahide Mori, Yoshito Takeda, Tomomi Yamada, Hiroshi Kida, Atsushi Kumanogoh	1
8	Fragment size and dynamics of EGFR-mutated tumor-derived DNA provide prognostic information regarding EGFR-TKI efficacy in patients with EGFR-mutated NSCLC 2022 ·Scientific Reports ·Kei Kunimasa, Kazumi Nishino, Yoshiharu Sato, Masahide Mori, Shôichi Ihara, Hidekazu Suzuki, Izumi Nagatomo, Toru Kumagai, Toshitaka Morishima, Fumio Imamura	5
9	Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin 2021 ·BMJ Open Respiratory Research ·Toru Arai, Hiroto Matsuoka, Masaki Hirose, Hiroshi Kida, Suguru Yamamoto, Yoshitaka Ogata, Masahide Mori, (unknown), Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Yoshikazu Inoue	3
10	Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial 2020 ·BMJ Open Respiratory Research ·Toru Arai, Hiroshi Kida, Yoshitaka Ogata, Satoshi Marumo, Hiroto Matsuoka, (unknown), Suguru Yamamoto, Masahide Mori, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Yoshikazu Inoue	4
11	Acute lung injury after plasma exchange in a patient with anti-MDA5 antibody-positive, rapidly progressive, interstitial lung disease：A case report 2020 ·Respiratory Medicine Case Reports ·Hiroyuki Kagawa, Kazuyuki Tsujino, Yuji Yamamoto, (unknown), Reina Hara, Takanori Matsuki, Kiyoharu Fukushima, (unknown), Kenji Yoshimura, Mari Miki, Keisuke Miki, Seigo Kitada, Masahide Mori, Hiroshi Kida	12
12	Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias 2019 ·Respirology ·Toru Arai, Hiroshi Kida, Yoshitaka Ogata, Satoshi Marumo, Hiroto Matsuoka, (unknown), Suguru Yamamoto, Masahide Mori, Chikatoshi Sugimoto, Kazunobu Tachibana, Masanori Akira, Ryuya Edahiro, Toshimitsu Hamasaki, Yoshikazu Inoue	10
13	Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report 2019 ·Thoracic Cancer ·Ryuya Edahiro, Mikako Ishijima, (unknown), Kohei Nishida, Takeshi Uenami, Masaki Kanazu, Yuki Akazawa, Yukihiro Yano, Masahide Mori	12
14	Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations 2018 ·Lung Cancer ·Ken Uchibori, Miyako Satouchi, Naoko Sueoka‐Aragane, Yoshiko Urata, Akemi Sato, Fumio Imamura, Takako Inoue, Motoko Tachihara, Kazuyuki Kobayashi, Nobuyuki Katakami, (unknown), Tomonori Hirashima, Kentaro Iwanaga, Masahide Mori, Keisuke Aoe, Satoshi Morita, Shunichi Negoro	13
15	Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer 2018 ·Cancer Chemotherapy and Pharmacology ·Taro Koba, Seigo Minami, (unknown), Kentaro Masuhiro, Hiromi Kimura, (unknown), Moto Yaga, Masahide Mori, Hiroyuki Kagawa, Takeshi Uenami, (unknown), Tomoyuki Otsuka, Suguru Yamamoto, Kiyoshi Komuta, Takashi Kijima	2
16	Exogenous lipoid pneumonia caused by repeated sesame oil pulling: a report of two cases 2015 ·BMC Pulmonary Medicine ·Muneyoshi Kuroyama, Hiroyuki Kagawa, Seigo Kitada, Ryoji Maekura, Masahide Mori, Hiroshi Hirano	31
17	Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease 2015 ·International Journal of COPD ·Ryoji Maekura, Toru Hiraga, Keisuke Miki, Seigo Kitada, Mari Miki, Kenji Yoshimura, Hiroshi Yamamoto, (unknown), Masahide Mori	24
18	A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109) 2014 ·Lung Cancer ·Yoshihiro Hattori, Miyako Satouchi, (unknown), Yoshiko Urata, Tsutomu Yoneda, Masahide Mori, Takashi Nishimura, (unknown), Toru Kumagai, Fumio Imamura, Shiro Fujita, Reiko Kaji, Akito Hata, Motoko Tachihara, Satoshi Morita, Shunichi Negoro	16
19	Sympathetic neurons modulate the beat rate of pluripotent cell-derived cardiomyocytes in vitro 2012 ·Integrative Biology ·(unknown), Kenta Shimba, Masahide Mori, Yuzo Takayama, Hiroyuki Moriguchi, Kiyoshi Kotani, Jong‐Kook Lee, Makoto Noshiro, Yasuhiko Jimbo	24
20	A case of pulmonary tuberculosis accompanied with immune thrombocytopenic purpura 2010 ·Respiratory Medicine CME ·Masahide Mori, Hiroyuki Sugahara, (unknown), (unknown), Teppei Sugano, (unknown), Yoshinobu Namba, Yukihiro Yano, Toshihiko Yamaguchi, Soichiro Yokota, Ryoji Maekura	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact